Product Name: Human CD52 Antibody (Alemtuzumab, Research Use)
Catalog Number: NBR-0138
Target Name: CD52
Trade Name: Alemtuzumab
Antibody Drug Description: Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. In CLL, it has been used as both a first line and second line treatment. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD52
Synonyms: HE5; EDDM5; CDW52
Target Description: CD52 (CD52 Molecule) is a Protein Coding gene. Diseases associated with CD52 include Listeria Meningitis and T-Cell Prolymphocytic Leukemia. Among its related pathways are Metabolism of proteins and Post-translational modification: synthesis of GPI-anchored proteins.
Ensembl: ENSG00000169442
Uniprot: P31358